Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
15
×
life sciences
national blog main
clinical trials
boston blog main
national top stories
boston top stories
new york top stories
new york blog main
san francisco blog main
san francisco top stories
drugs
biotech
boston
europe top stories
national
san diego blog main
san diego top stories
alnylam pharmaceuticals
europe blog main
onpattro
patisiran
akcea therapeutics
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
eli lilly
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
inotersen
marc goodman
pfizer
raleigh-durham blog main
raleigh-durham top stories
rna interference
roche
seattle blog main
What
drug
15
×
medicine
15
×
fda
approved
approval
new
alnylam
cancer
patients
pharmaceuticals
rnai
ago
announced
cannabis
digital
epilepsy
europe
gain
gets
interference
making
marijuana
market
marketing
nod
oks
post
risk
rna
second
specifically
therapy
treatment
weeks
weight
administration
afternoon
aid
alkermes
alnylam’s
Language
unset
Current search:
fda
×
drug
×
medicine
×
@bgr.com
3 years ago
FDA just authorized a breakthrough coronavirus drug that’s proven to save lives
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@slashgear.com
4 years ago
FDA says throw this popular heartburn medicine away over cancer risk
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com
5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@techcrunch.com
5 years ago
With CBD, marijuana-based medicine gets its first greenlight from the FDA
@venturebeat.com
8 years ago
This Microsoft Kinect-powered physical therapy app is FDA-approved